|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 405/06 | |
| C07D 319/16 | |||
| A61K 31/4025 | |||
| A61P 35/00 |
| (11) | Number of the document | 3599237 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19182732.8 |
| Date of filing the European patent application | 2010-11-24 | |
| (97) | Date of publication of the European application | 2020-01-29 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-24 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 26474809 P | 2009-11-27 | US |
| (72) |
LIU, Hanlan, US
WILLIS, Chris, US
BHARDWAJ, Renu, US
COPELAND, Diane P., US
HARIANAWALA, Abizer, US
SKELL, Jeffrey, US
MARSHALL, John, US
KOCHLING, Jianmei, US
PALACE, Gerard, US
PETERSCHMITT, Judith, US
SIEGEL, Craig, US
CHENG, Seng, US
|
| (73) |
Genzyme Corporation,
50 Binney Street, Cambridge, MA 02142,
US
|
| (54) | PHARMACEUTICAL COMPOSITION OF THE GLUCOSYLCERAMIDE SYNTHASE INHIBITOR ELIGLUSTAT FOR THE TREATMENT OF GAUCHER`S DISEASE COMPRISING ADJUSTING THE INDIVIDUAL THERAPEUTICAL DOSE TO THE P450 METABOLISM OF THE PATIENT |
| PHARMACEUTICAL COMPOSITION OF THE GLUCOSYLCERAMIDE SYNTHASE INHIBITOR ELIGLUSTAT FOR THE TREATMENT OF GAUCHER`S DISEASE COMPRISING ADJUSTING THE INDIVIDUAL THERAPEUTICAL DOSE TO THE P450 METABOLISM OF THE PATIENT |